Pancreatic cancer survival is improving through early detection, immune-based personalized therapies, insights into tumor–nervous system interactions, and organoid disease modelling.
Publisher Correction: Oncolytic virus VG161 in refractory hepatocellular carcinoma
Following treatment, a decreased proportion of epithelial and fibroblast cells was observed, whereas NK cells, T cells, and myeloid cells showed increased proportions, correcting an earlier misstatement.